The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine.
Department of Nuclear Medicine, PET/CT & Thyroid Centre, Oncology Institute of Southern Switzerland, CH-6500, Bellinzona, Switzerland. giorgiomednuc@libero.it.
Giorgio
G
Treglia
Tirocenter, Nuclear Medicine, Adnan Saygun caddesi, Nispetiye, Besiktas, Istanbul, Turkey.
Cumali
C
Aktolun
Humanitas Research Hospital, Department of Nuclear Medicine, Rozzano, Milan, Italy.|Humanitas University, Rozzano, Milan, Italy.
Arturo
A
Chiti
Bank of Cyprus Oncology Center, Nuclear Medicine Department, Nicosia, Cyprus.
Savvas
S
Frangos
Department of Nuclear Medicine, PET/CT & Thyroid Centre, Oncology Institute of Southern Switzerland, CH-6500, Bellinzona, Switzerland.
Luca
L
Giovanella
Radiology Center, Nuclear Medicine, Vienna, Austria.
Martha
M
Hoffmann
Department of Nuclear Medicine, Aristotle University, Papageorgiou Hospital, Thessaloniki, Greece.
Ioannis
I
Iakovou
Oncology Institute of Vojvodina, Department of Nuclear Medicine, Sremska Kamenica, Serbia.
Jasna
J
Mihailovic
Department of Nuclear Medicine, Rostock University Hospital, Rostock, Germany.
Bernd J
BJ
Krause
PET-CT Center Linz, Department of Nuclear Medicine & Endocrinology, Linz, Austria.
Werner
W
Langsteger
Department of Nuclear Medicine, RWTH University Hospital Aachen, Aachen, Germany.
Frederik A
FA
Verburg
Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany.
Markus
M
Luster
D001290:Attitude; D018278:Carcinoma, Neuroendocrine / Q000000981:diagnostic imaging*; D019317:Evidence-Based Medicine; D006801:Humans; D009683:Nuclear Medicine; D017410:Practice Guidelines as Topic; D012955:Societies, Medical; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging*